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Introduction {#sec005}
============

Diabetes is a serious global health problem, with the worldwide prevalence of diabetes having more than doubled in the past two decades \[[@pone.0184840.ref001]\]. Many of these subjects with diabetes, 60.6% in China \[[@pone.0184840.ref002]\] and 45.8% in the world \[[@pone.0184840.ref003]\], were undiagnosed, likely attributable to the prolonged asymptomatic phase between the onset of hyperglycemia and diagnosis of type 2 diabetes. Thus at the time of diagnosis, many patients with diabetes may have already developed chronic diabetic complications. In the UK Prospective Diabetes Study, for instance, the prevalence of retinopathy, proteinuria and impaired vibration perception was 36, 1.9 and 11.5% respectively in newly diagnosed patients \[[@pone.0184840.ref004]\]. In Hong Kong, the prevalence of retinopathy in those with newly diagnosed diabetes was reported to be 22% \[[@pone.0184840.ref005]\]. Early diagnosis, before the appearance of irreversible tissue damage, offers the best chance for complication prevention. Delivering diabetes screening to all adults in a populous country like China is difficult. However, opportunistic diabetes screening by a practical and effective screening tool, might have substantial public health benefit.

The list of diabetes risk factors is lengthy. It is important that the general public, healthcare professionals and policy makers are informed of the relative strength and the way to make use of the individual risk factors. Screening for diabetes through an assessment of risk factors with regard to an age- and body mass index (BMI)-based criteria (screening criteria); or with the American Diabetes Association (ADA) diabetes risk test (risk test) is recommended by the ADA to guide healthcare providers on whether or not a diagnostic test, i.e. blood glucose or HbA1c measurement, is necessary. The screening criteria suggested that adults aged 45 and older should be tested for diabetes every three years and testing should start earlier than 45 in overweight individuals with one or more of the risk factors for diabetes \[[@pone.0184840.ref006]\]. In Hong Kong, as 47.0% of our aging population were aged 45 or older in 2015 \[[@pone.0184840.ref007]\], a large proportion of our population would need regular diagnostic tests for diabetes if we adopt the screening criteria to test all subjects aged 45 or over \[[@pone.0184840.ref006]\]. A similar problem is anticipated in China, in particular in the urban areas, where population aging is evident, and regular blood glucose screening in all individuals older than 45 years would impose a huge burden to the public healthcare system. The ADA diabetes risk test, which was modified from the model developed using the data of NHANES 1999--2004 by Bang et al in 2009 \[[@pone.0184840.ref008]\], has been recommended as an additional option for screening \[[@pone.0184840.ref006]\]. We are interested to know which screening strategy better suits our aging Chinese population.

Here we evaluated the screening criteria and risk test using data from 1415 Hong Kong Chinese subjects who had no diabetes at prior assessments and returned for the 4^th^ Hong Kong Cardiovascular Risk Factors Prevalence Study (CRISPS) in 2010--2012. Our study provides insight on the performance of the two well validated, easily accessible and commonly used ADA diabetes screening recommendations, which involve non-invasive and easily measurable parameters, for diabetes screening in the Chinese population.

Methods {#sec006}
=======

Participants {#sec007}
------------

### CRISPS {#sec008}

Subjects were recruited from the CRISPS, a long-term, population-based, prospective study on the development of cardiovascular risk factors in Hong Kong. In 1995--1996 (CRISPS1), 2,895 unrelated Chinese subjects were invited randomly by their telephone numbers to undergo a detailed assessment \[[@pone.0184840.ref009]\]. Subjects were contacted for reassessment visits in 2000--2004 (CRISPS2), 2005--2008 (CRISPS3) and 2010--2012 (CRISPS4). Details of medical history taking, anthropometric and biochemical parameters measurements were described elsewhere \[[@pone.0184840.ref010], [@pone.0184840.ref011]\]. The presence of hypertension was defined as blood pressure ≥ 140/90 mmHg or receiving regular antihypertensive treatment \[[@pone.0184840.ref012]\]. A 75g OGTT was done in all subjects not taking antidiabetic medications when they attended assessment from CRISPS1 to CRISPS4. Diabetes cases were defined as being on medications for diabetes or having diabetes according to the World Health Organization (WHO) 1998 criteria: fasting glucose (FG) ≥ 7 mmol/L or 2hours post OGTT glucose (2-hG) ≥ 11.1 mmol/L.

All subjects with no diabetes at prior assessments (550 or 38.9% were known to have impaired glucose tolerance and/or impaired fasting glucose) who returned for follow-up at CRISPS4 were evaluated for the probability of having diabetes with reference to the ADA screening criteria and risk test, and the conclusion drawn was compared to their measured glycaemic status at the CRISPS4 assessment ([S1 File](#pone.0184840.s001){ref-type="supplementary-material"}). The ADA diabetes risk test is the risk score based on seven parameters including age, gender, family history of diabetes, history of gestational diabetes in women, history of hypertension, physical activity and body mass index of the individual. Subjects with a score of five or above are considered to have high risk of having diabetes \[[@pone.0184840.ref006]\]. The study protocol was approved by the Ethics Committee of the Faculty of Medicine, University of Hong Kong. Written informed consent was obtained from all subjects.

### Statistical analysis {#sec009}

All analyses were performed with SPSS version 23 software (SPSS, Inc., Chicago, IL). Results were presented as mean ± SD or median with interquartile range (IQR) as appropriate. For data that were not normally distributed, natural logarithmic transformation was applied before analyses. In univariate analyses, variables were compared between groups by one-way ANOVA for continuous data and Chi-square test for categorical data as appropriate. The area under the receiver operating characteristic (ROC) curve (AUROC) of the risk score was calculated to assess the performance in identification of diabetes subjects. The optimal cut-off for the risk score was determined by Youden's index \[[@pone.0184840.ref013]\] and compared to the ADA recommended cut-off value. The sensitivity, specificity, positive (PPV) and negative predictive values (NPV), diagnostic positive and negative likelihood ratios (DLRs) of the screening criteria and risk test were calculated for comparison. The number needed to test for blood glucose levels to diagnose one case of diabetes (NNT) was calculated by a reciprocal of absolute risk reduction \[[@pone.0184840.ref014]\]. Comparison of binary diagnostic tests in a paired study design were performed using R (package DTComPair) \[[@pone.0184840.ref015]\]. Differences in sensitivities and specificities were compared using McNemar's test \[[@pone.0184840.ref016]\]. Positive (PPV) and negative predictive value (NPV) were compared as proposed by Moskowitz and Pepe \[[@pone.0184840.ref017]\], and diagnostic positive and negative DLRs were compared using a regression model approach \[[@pone.0184840.ref018]\].

Results {#sec010}
=======

At CRISPS4, 1415 subjects (age: 58.1±10.2) with no diabetes at the last preceding assessment returned for follow up and 95 (6.7%) were diagnosed to have diabetes ([S1 File](#pone.0184840.s001){ref-type="supplementary-material"}). [Table 1](#pone.0184840.t001){ref-type="table"} shows that at CRISPS4, compared to those without diabetes, subjects with newly diagnosed diabetes were significantly older, more obese, had greater BMI and waist circumference (WC), and had higher systolic and diastolic blood pressures. They were also more likely to have hypertension (all p\<0.001).

10.1371/journal.pone.0184840.t001

###### Baseline characteristics of 1415 subjects at CRISPS4.

![](pone.0184840.t001){#pone.0184840.t001g}

  Variables                                                     All                 DM                  Non-DM              p-value
  ------------------------------------------------------------- ------------------- ------------------- ------------------- -------------
  Number                                                        1415                95                  1320                \--
  Age, years                                                    58.1±10.2           62.5±10.4           57.8±10.1           **\<0.001**
  Gender, % men                                                 45.7                46.3                45.6                0.893
  Smoking (%)                                                                                                               0.152
   Never smoke                                                  72.7                69.5                72.9                
   Former smoker                                                17.2                14.7                17.4                
   Current smoker                                               10.1                15.8                9.7                 
  Physical inactivity, %                                        49.2                50.5                49.1                0.787
  FG, mmol/L                                                    5.08±0.92           6.89±2.44           4.95±0.48           **\<0.001**
  2hG, mmol/L                                                   6.63±2.86           14.2±3.89           6.09±1.80           **\<0.001**
  A1C, %                                                        5.89±0.63           7.04±1.52           5.80±0.40           **\<0.001**
  A1C, mmol/mol                                                 40.9±6.93           53.4±16.6           39.9±4.42           **\<0.001**
  First degree of relative with DM, %                           28.7                41.1                27.8                **0.006**
  History of GDM, %                                             1.1                 2.1                 1.0                 0.303
  BMI, kg/m^2^                                                  24.1±3.47           26.4±4.10           24.0±3.36           **\<0.001**
  Waist circumference, cm                                       82.1±9.61           88.7±9.94           81.6±9.41           **\<0.001**
  Central obesity, %                                            36.1                63.2                34.2                **\<0.001**
  Waist-to-hip ratio                                            0.87±0.07           0.92±0.06           0.87±0.07           **\<0.001**
  SBP, mmHg                                                     125±18.5            134±18.7            124±18.3            **\<0.001**
  DBP, mmHg                                                     74.1±10.3           77.6±12.4           73.9±10.1           **0.001**
  HT, %                                                         39.1                67.4                37.1                **\<0.001**
  Triglycerides [\*](#t001fn002){ref-type="table-fn"}, mmol/L   1.10 (0.80--1.50)   1.50 (1.10--2.00)   1.10 (0.80--1.50)   **\<0.001**
  HDL- Cholesterol, mmol/L                                      1.49±0.41           1.31±0.34           1.51±0.41           **\<0.001**
  LDL- Cholesterol, mmol/L                                      3.12±0.82           3.28±0.89           3.11±0.81           0.055

Data presented as mean±SD or median (interquartile range);

\*log-transformed before analysis. Central obesity: WC ≥90 for men and 80 for women; HT, hypertension: BP ≥ 140 / 90mmHg or taking antihypertensives.

The AUROC of the risk test for identification of subject with diabetes was 0.725 with cut-off score being optimal at five, which was identical to the suggested cut-off by ADA ([Table 2](#pone.0184840.t002){ref-type="table"}). The statistical measures of the performance of the two screening methods in evaluation for the subjects at CRISPS4 are shown in [Table 3](#pone.0184840.t003){ref-type="table"}. The risk test had significantly better specificity (0.57 vs. 0.41, p\<0.001), positive predictive value (0.12 vs. 0.09, p\<0.001) and positive diagnostic likelihood ratio (1.85 vs. 1.37, p\<0.001). There was no significant difference in sensitivity, negative predictive value and negative diagnostic likelihood ratios, when compared with the screening criteria ([Table 3](#pone.0184840.t003){ref-type="table"}). In addition, the risk test had smaller NNT (11 vs. 18), compared to the screening criteria. 859 (60.7%) of the CRISPS4 subjects needed to have glucose measurement using the screening criteria but the number would reduce to 647 (45.7%) if the risk test was adopted as the screening tool.

10.1371/journal.pone.0184840.t002

###### Different cut-off points for the ADA diabetes risk test when applied in the CRISPS population (n = 1415).

![](pone.0184840.t002){#pone.0184840.t002g}

  AUROC (95% CI)                           Risk score Cut-off   Sensitivity, %   Specificity, %   PPV, %   NPV, %
  ---------------------------------------- -------------------- ---------------- ---------------- -------- --------
  **0.725 (0.673--0.776)**                 1                    100.00           0.00             6.7      0.0
  2                                        100.00               2.0              6.8              100.0    
  3                                        98.9                 9.9              7.3              99.2     
  4                                        90.5                 28.2             8.3              97.6     
  5[\*](#t002fn001){ref-type="table-fn"}   80.0                 56.7             11.7             97.5     
  6                                        53.7                 78.6             15.3             95.9     
  7                                        20.0                 94.2             19.8             94.2     
  8                                        3.2                  99.2             21.4             93.4     
  9+                                       0.00                 100.00           0.0              93.3     

\*Optimal cut-off for DM by Youden j index. PPV, Positive Predictive Value; NPV, Negative Predictive Value

10.1371/journal.pone.0184840.t003

###### Statistics measures of the performance of the two ADA screening strategies.

![](pone.0184840.t003){#pone.0184840.t003g}

  Diagnostic test statistic   ADA diabetes risk test Cut-off ≥5   ADA screening criteria   Difference between two tests   Ratio of two tests   p-value
  --------------------------- ----------------------------------- ------------------------ ------------------------------ -------------------- ---------------
  Sensitivity                 0.80 (0.72--0.88)                   0.81 (0.73--0.89)        -0.01 (-0.11--0.09)                                 0.8348
  Specificity                 0.57 (0.54--0.59)                   0.41 (0.38--0.43)        0.16 (0.13--0.19)                                   **\<0.00001**
  PPV                         0.12 (0.09--0.14)                   0.09 (0.07--0.11)                                       1.31 (1.16--1.48)    **\<0.00001**
  NPV                         0.98 (0.96--0.99)                   0.97 (0.95--0.98)                                       1.01 (0.99--1.02)    0.3050
  PDLR                        1.85 (1.64--2.08)                   1.37 (1.23--1.52)                                       1.35 (1.18--1.55)    **\<0.00001**
  NDLR                        0.35 (0.24--0.53)                   0.47 (0.31--0.71)                                       0.76 (0.45--1.27)    0.2895
  NNT                         11 (8.3--15.2)                      18 (12.3--30.16)                                                             

PPV, Positive Predictive Value; NPV, Negative Predictive Value; PDLR, Positive Diagnostic Likelihood Ratio; NDLR, Negative Diagnostic Likelihood Ratio; NNT, number needed to test for blood glucose levels to diagnose one case of diabetes

Discussion {#sec011}
==========

In this study, we showed that the suggested recommendations by ADA were effective in screening for undiagnosed cases of diabetes in our population. The ADA diabetes risk test has a higher specificity, positive predictive value and positive likelihood ratio, but lower NNT comparing to the screening criteria with similar sensitivity, NPV and NDRL. The risk test appears to be attractive as a non-invasive means to be used in the Chinese population as this approach has high NPV, which is important as diabetes can be ruled out with high confidence, and the NNT is low.

Both strategies include common conventional risk factors for diabetes but the number of risk factors involved and their application are different. The risk test is based on the scores calculated from seven health-related questions. The performance of its original model has been robustly validated in different populations \[[@pone.0184840.ref008]\]. While the screening criteria are based mainly on age and BMI as the perquisite factors for prediction, these two risk factors also have much contribution to the scores of the risk test. Despite the mean BMI of our participants being only 24, about 60% of the participants were overweight or obese ([Table 1](#pone.0184840.t001){ref-type="table"}) if we adopted the Asian BMI cut-off for overweight at 23 kg/m^2^ \[[@pone.0184840.ref019], [@pone.0184840.ref020]\] as recommended by the ADA \[[@pone.0184840.ref006]\]. The scoring of BMI for the on-line version of the risk test has also adopted the Asian criteria. Waist circumference, despite also being used as a predictor in other screening tools \[[@pone.0184840.ref021], [@pone.0184840.ref022]\], was not included in either screening methods recommended by ADA. This may have potential advantage as the measurement of body weight and height is more precise than waist circumference, which is heavily influenced by the anatomic location of measurement \[[@pone.0184840.ref023]\]. Age is well known to be an important risk factor for diabetes. The screening criteria suggests that even without the presence of other risk factors, regular testing of diabetes should start from the age of 45 and repeat every three years if the previous testing result is negative. If the ADA-suggested age cut point at 45 years is used, for aging populations like the one in CRISPS4, a very high proportion of the population would require regular testing for diabetes. On the other hand, the UK National Screening Committee does not currently recommend universal screening for diabetes based on age, but considers selective screening as part of an overall vascular risk assessment using risk factors as the first stage of selection, followed by the measurement of blood glucose \[[@pone.0184840.ref024]\]. Our findings would suggest that the ADA diabetes risk test may be considered as a better alternative to the ADA screening criteria in our aging population as fewer people would require regular testing for diabetes but the detection rate would be comparable.

Other health related questions asked in the risk test also include sex, history of gestational diabetes in woman, physical inactivity, family history of diabetes and history of hypertension, which are conventional risk factors for diabetes without involvement of measurements or invasive tests. The former three risk factors, however, did not show statistically significant difference in the diabetes subjects when compared with those without diabetes in our population ([Table 1](#pone.0184840.t001){ref-type="table"}). Each of these three risk factors, however, accounted only for one score point, which was significantly less than the score points related to age and BMI. This might explain why the risk test still performed well despite the inclusion of risk factors which were not statistically different between the diabetes and non-diabetes groups.

The definition of diabetes used in development of the ADA diabetes risk test was based on fasting plasma glucose value. In this CRISPS cohort, subjects were also considered to have diabetes if they fulfilled either the fasting glucose or 2-hG criteria. We did not use HbA1c as a diagnostic criterion for diabetes because the diagnostic criteria have changed over time with HbA1c being adopted from 2011 onwards \[[@pone.0184840.ref025]\]. The HbA1c criterion would have diagnosed an additional number of subjects with diabetes on top of the glucose criteria at CRISPS3 which might affect the number of people without diabetes at CRISPS4, i.e. the study time frame of this study \[[@pone.0184840.ref026]\]. Although currently HbA1c measurement may not be available throughout the world, it will be increasingly used clinically for confirming the diagnosis of diabetes, being a conveniently assessable parameter. If we included the HbA1c criterion for diagnosis of diabetes in our analysis, more diabetes cases (157, 11.1%) would be diagnosed in the cohort but, nonetheless, a similar conclusion would be drawn regarding the relative performance of the two screening tests.

The risk test also has the advantage of being simple and applicable in various community or clinical settings. It can be quickly calculated even manually. The time required is minimal and the use of calculator or computer is not essential. Apart from being user-friendly, the risk test has the advantage of better accuracy than existing scores from various populations with an AUROC of 0.79 from the original 6 risk factors model \[[@pone.0184840.ref008]\]. When applied in the CRISPS4 population, the risk test still maintained reasonably good accuracy with an AUROC of 0.725. This paper is, to our knowledge, the first paper to evaluate this risk test in a homogenous urban Chinese population. Our findings suggest that the well validated ADA diabetes test also has a good validity in detecting Chinese adults with undiagnosed diabetes in our population and could be considered as an option for screening of diabetes in Chinese.

In interpreting our findings, we took into account several limitations. First, at CRISPS4, the average age of the studied subjects was 58, with 43.9% of the subjects aged 45 or above ([Table 1](#pone.0184840.t001){ref-type="table"}). This was not representative of the general population but would be representative of an older population likely to be offered diabetes screening. Second, in a long-term study, there are inevitable losses to follow-up, including deaths. Comparing the baseline characteristics at CRISPS1, the missing subjects were older (49±14 vs. 43±11, P\<0.001), more of them were men (51.8% vs. 46.2%, P = 0.003), ever smokers (30.5% vs. 21.7%, P\<0.001) and with hypertension (24.6% vs. 13.0% P\<0.001). Fewer of them had family history of diabetes (15.2% vs. 18.3%, P = 0.026) The cohort might become less representative of the general population as the defaulted subjects were more likely to be the high risk cases. Our study however has the strengths of being a long-term cohort study in a genetically homogenous Chinese population. The findings should be of considerable value in diabetes screening in Mainland China with its huge aging population.

Conclusions {#sec012}
===========

In conclusion, we recommend using the ADA diabetes risk test for identification of individuals with increased risk of diabetes in the Chinese population. The test involves only personal medical information and simple non-invasive measurements which should be acceptable by healthcare providers as well as individuals with different education levels. It can also be easily adopted as a public health policy for identifying people with undiagnosed diabetes for early and appropriate treatment to prevent the long-term diabetic complications \[[@pone.0184840.ref027]\]. Whether this diabetes risk test is more effective than the age-based strategy for diabetes screening is an important public health question to be further investigated in other aging populations.

Supporting information {#sec013}
======================

###### Baseline characteristics and risk of diabetes as assessed by the screening criteria or risk test of 1415 subjects at CRISPS4.

Screening criteria, the age- and body mass index-based screening criteria; risk test, the ADA diabetes risk test.
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